• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Imaging in immune checkpoint inhibitor-induced polymyalgia rheumatica.

作者信息

van der Geest Kornelis S M, Sandovici Maria, Rutgers Abraham, Hiltermann T Jeroen N, Oosting Sjoukje F, Slart Riemer H J A, Brouwer Elisabeth

机构信息

Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands

Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.

出版信息

Ann Rheum Dis. 2022 Oct;81(10):e210. doi: 10.1136/annrheumdis-2020-217381. Epub 2020 Apr 2.

DOI:10.1136/annrheumdis-2020-217381
PMID:32241799
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9484368/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aed1/9484368/efb779432bd5/annrheumdis-2020-217381f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aed1/9484368/efb779432bd5/annrheumdis-2020-217381f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aed1/9484368/efb779432bd5/annrheumdis-2020-217381f01.jpg

相似文献

1
Imaging in immune checkpoint inhibitor-induced polymyalgia rheumatica.免疫检查点抑制剂诱发的风湿性多肌痛的影像学表现
Ann Rheum Dis. 2022 Oct;81(10):e210. doi: 10.1136/annrheumdis-2020-217381. Epub 2020 Apr 2.
2
Management of immune checkpoint inhibitor-induced polymyalgia rheumatica.免疫检查点抑制剂诱导的风湿性多肌痛的管理。
Ann Rheum Dis. 2022 Dec;81(12):e263. doi: 10.1136/annrheumdis-2020-218276. Epub 2020 Sep 4.
3
Immune Checkpoint Inhibitor-Associated Polymyalgia Rheumatica/Giant Cell Arteritis Occurring in a Patient After Treatment With Nivolumab.纳武单抗治疗后患者出现的免疫检查点抑制剂相关多肌痛/巨细胞动脉炎
J Clin Rheumatol. 2021 Dec 1;27(8S):S555-S556. doi: 10.1097/RHU.0000000000001012.
4
Features of polymyalgia rheumatica-like syndrome after immune checkpoint inhibitor therapy.免疫检查点抑制剂治疗后风湿性多肌痛样综合征的特征
Ann Rheum Dis. 2022 Mar;81(3):e52. doi: 10.1136/annrheumdis-2020-217225. Epub 2020 Mar 18.
5
Polymyalgia rheumatica and giant cell arteritis induced by immune checkpoint inhibitors: A systematic literature review highlighting differences from the idiopathic forms.免疫检查点抑制剂诱导的巨细胞动脉炎和风湿性多肌痛：系统文献综述强调与特发性疾病的差异。
Autoimmun Rev. 2024 Jul-Aug;23(7-8):103589. doi: 10.1016/j.autrev.2024.103589. Epub 2024 Aug 6.
6
Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement.免疫检查点抑制剂介导的风湿性多肌痛与原发性风湿性多肌痛：疾病特征和治疗需求的比较
Rheumatology (Oxford). 2025 Feb 1;64(2):771-779. doi: 10.1093/rheumatology/keae099.
7
Polymyalgia Rheumatica and Giant Cell Arteritis.风湿性多肌痛和巨细胞动脉炎。
JAMA. 2020 Sep 8;324(10):993-994. doi: 10.1001/jama.2020.10155.
8
Clinical, laboratory and ultrasonographic findings at baseline predict long-term outcome of polymyalgia rheumatica: a multicentric retrospective study : Polymyalgia rheumatica predicted by ultrasonographic findings polymyalgia rheumatica outcome predicted early by ultrasound.临床、实验室和超声检查结果可预测巨细胞动脉炎的长期预后：一项多中心回顾性研究：超声检查结果可预测巨细胞动脉炎，超声检查可早期预测巨细胞动脉炎的预后。
Intern Emerg Med. 2023 Oct;18(7):1929-1939. doi: 10.1007/s11739-023-03373-x. Epub 2023 Jul 27.
9
Serum immunoglobulin G4 in giant cell arteritis and polymyalgia rheumatica.巨细胞动脉炎和风湿性多肌痛中的血清免疫球蛋白G4
Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):94-97. Epub 2016 Dec 2.
10
Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group.免疫检查点抑制剂引起的炎症性关节炎和巨细胞动脉炎的结局领域的识别：OMERACT irAE 工作组的范围综述。
Semin Arthritis Rheum. 2023 Feb;58:152110. doi: 10.1016/j.semarthrit.2022.152110. Epub 2022 Oct 26.

引用本文的文献

1
Soluble Co-Inhibitory Immune Checkpoint Molecules Are Increased in Patients With Polymyalgia Rheumatica Without Significant Correlations With Clinical Status: A Case-Control Study.可溶性共抑制性免疫检查点分子在风湿性多肌痛患者中增加，与临床状态无显著相关性：一项病例对照研究。
ACR Open Rheumatol. 2025 May;7(5):e70045. doi: 10.1002/acr2.70045.
2
Rheumatic adverse events of immune checkpoint inhibitors in cancer immunotherapy.癌症免疫治疗中免疫检查点抑制剂的风湿性不良事件。
Expert Rev Clin Immunol. 2024 Aug;20(8):873-893. doi: 10.1080/1744666X.2024.2323966. Epub 2024 Mar 19.
3
Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement.

本文引用的文献

1
Polymyalgia rheumatica-like syndrome from checkpoint inhibitor therapy: case series and systematic review of the literature.免疫检查点抑制剂治疗相关肌痛性皮肌炎样综合征：病例系列及文献系统综述。
RMD Open. 2019 Apr 25;5(1):e000906. doi: 10.1136/rmdopen-2019-000906. eCollection 2019.
2
Addressing immune-related adverse events of cancer immunotherapy: how prepared are rheumatologists?应对癌症免疫治疗的免疫相关不良事件：风湿病学家准备得如何？
Ann Rheum Dis. 2019 Jun;78(6):860-862. doi: 10.1136/annrheumdis-2018-214748. Epub 2019 Jan 18.
3
FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC.
免疫检查点抑制剂介导的风湿性多肌痛与原发性风湿性多肌痛：疾病特征和治疗需求的比较
Rheumatology (Oxford). 2025 Feb 1;64(2):771-779. doi: 10.1093/rheumatology/keae099.
4
Imaging Findings in Patients with Immune Checkpoint Inhibitor-Induced Arthritis.免疫检查点抑制剂诱导的关节炎患者的影像学表现
Diagnostics (Basel). 2022 Aug 13;12(8):1961. doi: 10.3390/diagnostics12081961.
5
Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica.用于巨细胞动脉炎和风湿性多肌痛诊断与监测的炎症靶点和细胞的新型PET成像
Front Med (Lausanne). 2022 Jun 6;9:902155. doi: 10.3389/fmed.2022.902155. eCollection 2022.
6
Monitoring and Management of the Patient with Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis: Current Perspectives.免疫检查点抑制剂诱导的炎性关节炎患者的监测与管理：当前观点
J Inflamm Res. 2022 May 25;15:3105-3118. doi: 10.2147/JIR.S282600. eCollection 2022.
7
Comparison and validation of FDG-PET/CT scores for polymyalgia rheumatica.FDG-PET/CT 评分在巨细胞动脉炎中的比较和验证。
Rheumatology (Oxford). 2022 Mar 2;61(3):1072-1082. doi: 10.1093/rheumatology/keab483.
8
Expert Perspective: Immune Checkpoint Inhibitors and Rheumatologic Complications.专家视角：免疫检查点抑制剂与风湿免疫并发症。
Arthritis Rheumatol. 2021 Apr;73(4):553-565. doi: 10.1002/art.41587. Epub 2021 Mar 5.
FDG-PET/CT（A）成像在大血管血管炎和巨细胞动脉炎中的应用：EANM、SNMMI 和 PET 兴趣小组（PIG）的联合程序建议，并得到 ASNC 的认可。
Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1250-1269. doi: 10.1007/s00259-018-3973-8. Epub 2018 Apr 11.
4
Ultrasonography and magnetic resonance imaging changes in patients with polymyalgia rheumatica treated by tocilizumab.托珠单抗治疗的巨细胞动脉炎患者的超声和磁共振成像变化。
Arthritis Res Ther. 2018 Jan 25;20(1):11. doi: 10.1186/s13075-017-1499-2.
5
Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer-clinical aspects and relationship with tumour response: a single-centre prospective cohort study.癌症患者免疫检查点抑制剂相关风湿性疾病的临床特征及其与肿瘤应答的关系：单中心前瞻性队列研究。
Ann Rheum Dis. 2018 Mar;77(3):393-398. doi: 10.1136/annrheumdis-2017-212257. Epub 2017 Nov 16.
6
Fusion of positron emission tomography/computed tomography with magnetic resonance imaging reveals hamstring peritendonitis in polymyalgia rheumatica.正电子发射断层扫描/计算机断层扫描与磁共振成像融合显示巨细胞动脉炎中的腘绳肌腱周炎。
Rheumatology (Oxford). 2018 Feb 1;57(2):345-353. doi: 10.1093/rheumatology/kex411.
7
2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.2012 年多肌痛的临时性分类标准：欧洲抗风湿病联盟/美国风湿病学会合作倡议。
Ann Rheum Dis. 2012 Apr;71(4):484-92. doi: 10.1136/annrheumdis-2011-200329.